V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270010563 | 270006209 | 1.79 | 85 | Neo-adjuvant (N) | null | 2016-09-09 | CETUXIMAB | null | null | 270002085 | SCOT TRIAL |
| 270010564 | 270006209 | 1.55 | 95 | Curative (C) | 2013-12-02 | 2013-12-17 | Cisplatin + Etoposide (3 day) | 2 | null | 270002085 | CAPECITABINE + MITOMYCIN + RT |
| 270010565 | 270006209 | 1.75 | null | Palliative (P) | 2017-10-06 | 2017-10-14 | CARBOPLATIN + RT | N | N | 270002085 | CARBOPLATIN + ETOPOSIDE |
| 270010566 | 270006210 | 1.86 | null | Adjuvant (A) | 2018-05-05 | 2018-05-08 | Bevacizumab 10mg/kg | N | N | 270002435 | CETUXIMAB + RT |
| 270010567 | 270006211 | 1.9 | 93 | Curative (C) | 2016-12-08 | 2016-12-08 | CAP + RT | N | N | 270002450 | CETUXIMAB + RT |
| 270010568 | 270006212 | 1.59 | 55.4 | Palliative (P) | 2015-03-24 | 2015-03-27 | CETUXIMAB + RT | N | N | 270002503 | CVP R |
| 270010569 | 270006213 | null | 80 | Curative (C) | 2016-11-01 | 2016-11-01 | Carboplatin + Etoposide iv&po | N | N | 270002550 | FLUOROURACIL + RT |
| 270010570 | 270006214 | 1.61 | 82.3 | null | 2015-07-25 | 2015-08-14 | CAP + RT | N | N | 270002563 | BCG |
| 270010571 | 270006215 | 1.65 | 143.8 | null | 2017-05-10 | 2017-05-18 | CVP R | N | N | 270002604 | CETUXIMAB |
| 270010572 | 270013022 | 1.63 | 88 | Curative (C) | 2018-06-13 | 2018-06-13 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 270002618 | MITOMYCIN INTRAVESICULAR |
| 270010573 | 270006216 | 1.76 | 75.3 | Adjuvant (A) | 2018-11-23 | 2018-11-28 | SCOT TRIAL | 02 | N | 270002673 | CAPE + CARBOPLATIN + CETUXIMAB |
| 270010574 | 270006217 | 1.97 | 71 | Palliative (P) | 2018-01-31 | 2018-02-27 | Bevacizumab + Cape + Oxali 21day | N | N | 270002681 | CETUXIMAB + RT |
| 270010575 | 270006218 | 1.6 | 95.2 | Curative (C) | 2014-01-14 | 2014-01-20 | Carboplatin AUC 6 - 10 | N | N | 270002807 | CETUXIMAB + MDG |
| 270010576 | 270006219 | null | 74.8 | Palliative (P) | 2016-03-24 | 2016-04-21 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270002866 | CAPECITABINE + IRINOTECAN |
| 270010577 | 270006220 | 1.75 | null | Curative (C) | null | 2017-04-09 | Docetaxel 75mg/m2 (21 day) | null | null | 270003136 | CARBOPLATIN + RT |
| 270010578 | 270006220 | 1.85 | 56.7 | Palliative (P) | 2017-07-09 | 2017-07-12 | Bevacizumab + Capecitabine | N | N | 270003136 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270010579 | 270006220 | 1.7 | 62.2 | null | 2017-01-06 | 2017-01-17 | Carboplatin AUC 6 - 10 | 2 | N | 270003136 | CARBO + FLUOROURACIL |
| 270010580 | 270006220 | 1.67 | null | Palliative (P) | 2018-12-31 | 2019-01-17 | GemCarbo Days 1+8 | N | N | 270003136 | CISPLATIN + ETOPOSIDE |
| 270010581 | 270006220 | null | null | Adjuvant (A) | 2018-04-02 | 2018-04-03 | null | Y | N | 270003136 | CVD |
| 270010582 | 270006221 | 1.7 | 47.8 | Palliative (P) | null | 2017-10-15 | Bevacizumab + Cape + Oxali 21day | N | N | 270003504 | CISPLATIN + FLUOROURACIL + RT |
| 270010583 | 270006222 | 1.64 | 65.6 | Palliative (P) | 2016-10-10 | 2016-10-14 | CARBOPLATIN + RT | 2 | N | 270003570 | CARBOPLATIN + RT |
| 270010584 | 270006223 | null | 106 | Palliative (P) | 2016-05-12 | 2016-05-26 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270003575 | CETUXIMAB + IRINOTECAN + MDG |
| 270010585 | 270006224 | null | 64 | Curative (C) | 2015-05-23 | 2017-01-08 | Carboplatin AUC 6 - 10 | N | N | 270003595 | FLUOROURACIL + RT |
| 270010586 | 270006225 | null | null | Palliative (P) | 2016-01-26 | 2016-02-23 | Lenalidomide 25mg (Cycle 1 to 25) | N | N | 270003639 | CISPLATIN + FLUOROURACIL + RT |
| 270010587 | 270013024 | 1.72 | 79.2 | null | 2018-09-14 | 2018-09-26 | Cetuximab + Radiotherapy Load | N | N | 270003668 | CAP + RT |
| 270010588 | 270016127 | 1.61 | 90.1 | Palliative (P) | 2016-08-11 | 2016-09-08 | LOPP | N | N | 270003718 | CHOP |
| 270010589 | 270006226 | 1.86 | 84 | Curative (C) | 2018-12-19 | 2018-12-26 | BEAM | N | N | 270003817 | RITUXIMAB |
| 270010590 | 270006226 | 1.79 | null | Palliative (P) | 2015-02-10 | 2015-02-24 | Gemcitabine weekly | Y | N | 270003817 | CARBOPLATIN |
| 270010591 | 270006227 | 1.6 | null | Palliative (P) | 2018-07-19 | 2018-07-22 | Capecitabine (14 days)+Carboplatin | N | N | 270004101 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270010592 | 270006228 | 1.78 | 56.6 | Curative (C) | 2018-04-08 | 2018-04-14 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 270004178 | CHLVPP/PABLOE |
| 270010593 | 270006229 | 1.56 | 67.95 | Palliative (P) | 2017-03-09 | 2017-04-02 | Cetuximab +Cisplatin + FU (Cycle 1) | N | Y | 270004181 | CAPECITABINE + IRINOTECAN |
| 270010594 | 270006230 | 1.6 | 65 | null | 2018-02-05 | 2018-02-06 | ECF | Y | N | 270004483 | CARBOPLATIN + ETOPOSIDE |
| 270010595 | 270006230 | 1.73 | 54.5 | null | 2017-02-18 | 2017-02-21 | BEAM + FLUDARABINE | 02 | N | 270004483 | LOPP |
| 270010596 | 270006231 | null | 62 | Adjuvant (A) | 2019-07-05 | 2019-07-05 | CETUXIMAB + RT | null | N | 270004503 | NOT MATCHED |
| 270010597 | 270006232 | 1.58 | 103.6 | Palliative (P) | 2015-02-18 | 2015-02-19 | Bevacizumab + Cape + Oxali 21day | 02 | N | 270004538 | CAPECITABINE + IRINOTECAN |
| 270010598 | 270006233 | 1.63 | 97 | Curative (C) | 2016-04-01 | 2016-04-03 | Cetuximab + CISPLATIN + FLUOROURACIL | 02 | N | 270004589 | BORTEZOMIB |
| 270010599 | 270006234 | 1.67 | 52.8 | Palliative (P) | 2017-09-22 | 2017-10-10 | Carboplatin + Etoposide IV 3 day | 2 | N | 270004595 | CETUXIMAB + IRINOTECAN + MDG |
| 270010600 | 270006235 | 1.7 | 85 | Palliative (P) | 2016-12-06 | 2016-12-09 | CETUXIMAB | N | N | 270004603 | ENZALUTAMIDE |
| 270010601 | 270006236 | null | 78.75 | Neo-adjuvant (N) | 2014-05-27 | 2014-06-01 | Cisplatin + Vinorelbine (PO) | N | null | 270004632 | GEMCITABINE |
| 270010602 | 270013027 | 1.74 | 74 | Palliative (P) | 2019-03-26 | 2019-04-09 | CAPECITABINE + CETUXIMAB + IRINOTECAN | 2 | Y | 270004680 | CARBOPLATIN + CETUXIMAB + FU |
| 270010603 | 270006237 | 1.52 | 57 | Curative (C) | 2015-06-22 | 2015-07-06 | CETUXIMAB + RT | N | N | 270004767 | CARBOPLATIN |
| 270010604 | 270006238 | 1.64 | 73.6 | Curative (C) | 2018-01-02 | 2018-01-02 | CVP R | N | N | 270004836 | CARBOPLATIN + RT |
| 270010605 | 270006238 | 1.62 | 60 | Palliative (P) | 2016-09-19 | 2016-10-10 | Cetuximab +Cisplatin + FU (Cycle 1) | N | Y | 270004836 | CETUXIMAB |
| 270010606 | 270006239 | 1.7 | 77 | Curative (C) | 2019-03-08 | 2019-03-15 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 2 | N | 270004873 | CARBOPLATIN + VINORELBINE |
| 270010607 | 270006240 | 1.68 | 104.7 | Curative (C) | 2017-02-04 | 2017-02-06 | CETUXIMAB | 02 | N | 270004881 | CISPLATIN + ETOPOSIDE |
| 270010608 | 270006240 | 1.9 | 0 | Palliative (P) | 2018-07-28 | 2018-07-29 | CARBOPLATIN + RT | N | N | 270004881 | FOXTROT TRIAL |
| 270010609 | 270006241 | null | 43 | Curative (C) | 2017-01-12 | 2017-01-22 | Capecitabine + Cisplatin | N | N | 270004960 | CISPLATIN + ETOPOSIDE |
| 270010610 | 270006242 | null | 98.6 | Palliative (P) | 2019-01-12 | 2019-01-19 | GEMCARBO | N | null | 270004970 | TCF |
| 270010611 | 270006243 | 1.75 | 96 | Adjuvant (A) | 2014-05-29 | 2014-06-04 | Cetuximab + FLUOROURACIL | N | N | 270004979 | CETUXIMAB + RT |
| 270010612 | 270006244 | 1.55 | 62.5 | Palliative (P) | 2016-08-11 | 2016-08-31 | Irinotecan | 02 | N | 270005105 | CARBOPLATIN + ETOPOSIDE |